SPRR1B

SPRR1B is a small proline-rich protein that functions as a structural component of the cornified envelope in stratified and metaplastic epithelia, contributing to epithelial barrier formation, squamous differentiation, and wound healing. Its amino-terminal glutamine clusters (Gln4–Gln6, Gln22–Gln25) serve as transglutaminase acceptor sites required for covalent cross-linking into cornified envelopes, while its carboxyl terminus governs protein stability (PMID:10681560). Transcription of SPRR1B is driven by a PKCδ/Ras/MEKK1/MKK1/ERK5 cascade converging on AP-1 (Fra1/Fra2–c-Jun) elements within the proximal promoter, and is further induced by inflammatory cytokines (IL-1β, IFN-γ, TNF-α) and regulated post-transcriptionally by miR-499a-5p and miR-330-5p (PMID:10918063, PMID:11313996, PMID:12091247, PMID:18172072, PMID:34808501). Functionally, SPRR1B promotes keratinocyte migration via STAT3 activation, accelerates G0/G1 entry, and acts upstream of p38 MAPK phosphorylation, linking it to wound healing, cell cycle withdrawal, and inflammatory epithelial remodeling (PMID:39300285, PMID:12832281, PMID:33620575).

1. 2000 High

   Identifying the structural requirements for SPRR1 incorporation into the cornified envelope resolved how this small protein participates in barrier assembly: amino-terminal Gln clusters are transglutaminase substrates for cross-linking, while the C-terminus controls protein stability.

   Evidence Site-directed and deletion mutagenesis of Flag-SPRR1 in primary human tracheobronchial epithelial cells with immunological detection of envelope incorporation

   PMID:10681560

   Open questions at the time

   • The specific transglutaminase(s) catalyzing cross-linking of SPRR1B in vivo are not identified
   • How the C-terminal lysine controls protein stability (proteasomal degradation vs. other mechanism) is unknown
2. 2000 High

   Mapping the signaling cascade upstream of SPRR1B transcription established that PKCδ, Ras, MEKK1, and MKK1 form a linear pathway converging on AP-1, with ERK1/2 dispensable despite MEK1/2 involvement, defining a non-canonical MAPK route to squamous differentiation gene expression.

   Evidence Dominant-negative and constitutively active kinase mutants combined with pharmacological inhibitors and reporter assays in tracheobronchial epithelial cells

   PMID:10918063

   Open questions at the time

   • The direct phosphorylation substrate of MKK1 that activates AP-1 in this pathway was unresolved at this stage
   • Whether the same cascade operates in non-airway squamous epithelia was not tested
3. 2001 High

   Demonstrating differential AP-1 composition at the SPRR1B promoter in normal versus malignant bronchial cells explained how SPRR1B is silenced during malignant transformation: Fra1 activates and Fra2 represses the promoter via two TRE sites within −152 bp.

   Evidence In vivo footprinting, EMSA, and AP-1 overexpression with reporter assays in matched normal and malignant bronchial epithelial cells

   PMID:11313996

   Open questions at the time

   • Whether Fra1/Fra2 switch is driven by epigenetic changes at their own loci or by upstream signaling alterations is unknown
   • No chromatin immunoprecipitation for histone marks at the SPRR1B locus was performed
4. 2002 Medium

   Placing ERK5 (BMK1) upstream of AP-1-dependent SPRR1B transcription completed the kinase cascade and resolved the identity of the ERK1/2-independent MAP kinase branch required for inducible expression.

   Evidence Dominant-negative ERK5/MEK5 overexpression with reporter assays and c-Jun rescue in H441 Clara-like cells

   PMID:12091247

   Open questions at the time

   • Direct ERK5-mediated phosphorylation of c-Jun or another AP-1 component was not demonstrated biochemically
   • Findings in a single cell line (H441)
5. 2003 Medium

   Showing that inducible SPRR1B overexpression drives G0/G1 entry linked this structural envelope protein to cell cycle control, suggesting a dual role in differentiation-associated growth arrest.

   Evidence Ecdysone-inducible SPRR1B expression system in CHO and tumor cell lines with cell cycle analysis

   PMID:12832281

   Open questions at the time

   • The molecular mechanism by which SPRR1B influences cell cycle machinery (CDK inhibitors, Rb pathway) is unknown
   • Tetraploidy from prolonged overexpression was not mechanistically explained
6. 2008 Medium

   Demonstrating that multiple inflammatory cytokines (IL-1β, IFN-γ, TNF-α) directly induce SPRR1B in ocular surface epithelium, and that T-cell-driven inflammation causes SPRR1B-positive squamous metaplasia in vivo, established inflammation as a physiological driver of SPRR1B expression.

   Evidence In vitro cytokine stimulation with RT-PCR/IHC; adoptive transfer of CD4+ T cells from aire-deficient mice; validation in human Sjögren's syndrome tissue

   PMID:18172072

   Open questions at the time

   • Which cytokine-activated transcription factors directly bind the SPRR1B promoter (NF-κB, STAT, or AP-1) was not resolved
   • Whether cytokine induction uses the same PKCδ/ERK5 axis or a parallel pathway is unknown
7. 2021 Medium

   Identifying SPRR1B as a target of miR-499a-5p (sponged by lncRNA DGUOK-AS1) and showing that SPRR1B silencing reverses pro-tumorigenic phenotypes revealed a post-transcriptional regulatory layer controlling SPRR1B abundance in squamous carcinoma.

   Evidence Luciferase reporter assays validating direct miRNA–SPRR1B 3′-UTR interaction, siRNA knockdown and functional rescue in cervical cancer cell lines

   PMID:34808501

   Open questions at the time

   • Whether miR-499a-5p regulation of SPRR1B operates in normal epithelial differentiation contexts is untested
   • Endogenous stoichiometry of ceRNA network components was not measured
8. 2022 Medium

   A second ceRNA axis (lncRNA HAGLROS/miR-330-5p/SPRR1B) was validated with in vivo xenograft confirmation, reinforcing miRNA-mediated control of SPRR1B and extending it to bladder cancer.

   Evidence Luciferase reporter assays, miRNA mimic/inhibitor experiments, siRNA knockdown, and xenograft tumor model

   PMID:35664787

   Open questions at the time

   • Whether miR-330-5p and miR-499a-5p cooperatively regulate SPRR1B or target distinct cell contexts is unknown
   • The contribution of SPRR1B versus other miR-330-5p targets to the in vivo phenotype was not isolated
9. 2024 Medium

   Identifying SPRR1B as a STAT3-induced gene in oral mucosal keratinocytes that is required for efficient migration established a direct functional role in wound healing and explained the faster healing of oral mucosa compared to skin.

   Evidence Single-cell RNA-seq, SPRR1B knockdown migration assays, and murine wound healing model

   PMID:39300285

   Open questions at the time

   • How SPRR1B mechanistically promotes migration (cytoskeletal remodeling, adhesion modulation) is unknown
   • Whether STAT3 directly binds the SPRR1B promoter or acts indirectly was not resolved

• The mechanism by which SPRR1B—a small, intrinsically disordered envelope protein—signals to intracellular pathways (p38 MAPK, cell cycle machinery, STAT3-dependent migration) remains unresolved; whether these activities require its structural cross-linking function or represent a moonlighting role is unknown.
• No binding partners mediating SPRR1B's signaling functions have been identified
• No structural or biophysical characterization of SPRR1B has been reported
• Whether SPRR1B signaling functions operate in its soluble versus cross-linked form is untested